Inogen | INGN - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Abbott USD 3.13B 125M 2025-12
Accuray USD 127.32M 500.16M 2025-09
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Chart Industries USD 136M 9.3M 2025-09
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Orthofix International USD 130.35M 11.31M 2025-12
Philips EUR 1.31B 127M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
X T L Biopharmaceuticals USD 706K 50K 2024-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12